-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
-
-
-
-
-
-
-
Zevra Therapeutics (ZVRA) Strength Tied to Unconfirmed Market Chatter
-
-
-
-
-
-
-
Zevra Therapeutics (ZVRA) Files Definitive Proxy Statement and Mails Letter to Stockholders
-
-
-
-
-
-
-
Zevra Therapeutics (ZVRA) 900 contracts of August 7 puts trade at $1.10
-
-
-
-
-
-
-
Zevra Therapeutics, Inc. (ZVRA) PT Raised to $21 at Roth/MKM
-
-
-
-
-
-
-
Roth/MKM Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Zevra Therapeutics, Inc. (ZVRA)
408,277 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

